Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 95 Shares of The Clorox Company (NYSE:CLX)

Town & Country Bank & Trust CO dba First Bankers Trust CO cut its holdings in shares of The Clorox Company (NYSE:CLX) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,939 shares of the company’s stock after selling 95 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Clorox were worth $802,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Catalyst Capital Advisors LLC bought a new stake in Clorox during the 3rd quarter worth approximately $54,000. Los Angeles Capital Management LLC lifted its position in Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after buying an additional 9,037 shares during the last quarter. Natixis Advisors LLC grew its holdings in shares of Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after acquiring an additional 13,038 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on CLX shares. Barclays decreased their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. raised their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and an average price target of $156.54.

Clorox Stock Performance

CLX stock opened at $162.35 on Tuesday. The stock has a 50-day moving average price of $163.66 and a 200-day moving average price of $157.66. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The firm has a market cap of $20.10 billion, a PE ratio of 56.57, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.49 EPS. As a group, equities research analysts expect that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.